187 related articles for article (PubMed ID: 21881044)
1. Critical role for Syk in responses to vascular injury.
Andre P; Morooka T; Sim D; Abe K; Lowell C; Nanda N; Delaney S; Siu G; Yan Y; Hollenbach S; Pandey A; Gao H; Wang Y; Nakajima K; Parikh SA; Shi C; Phillips D; Owen W; Sinha U; Simon DI
Blood; 2011 Nov; 118(18):5000-10. PubMed ID: 21881044
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
3. Selective spleen tyrosine kinase inhibition delays autoimmune arthritis in mice.
Zhang Z; Cao C; Sun S; Xu Q
Mol Med Rep; 2015 Aug; 12(2):2902-6. PubMed ID: 25955571
[TBL] [Abstract][Full Text] [Related]
4. The selective SYK inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.
Spurgeon SE; Coffey G; Fletcher LB; Burke R; Tyner JW; Druker BJ; Betz A; DeGuzman F; Pak Y; Baker D; Pandey A; Hollenbach SJ; Sinha U; Loriaux MM
J Pharmacol Exp Ther; 2013 Feb; 344(2):378-87. PubMed ID: 23220742
[TBL] [Abstract][Full Text] [Related]
5. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
[TBL] [Abstract][Full Text] [Related]
6. Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.
Hoellenriegel J; Coffey GP; Sinha U; Pandey A; Sivina M; Ferrajoli A; Ravandi F; Wierda WG; O'Brien S; Keating MJ; Burger JA
Leukemia; 2012 Jul; 26(7):1576-83. PubMed ID: 22362000
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
[TBL] [Abstract][Full Text] [Related]
8. Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces.
Jooss NJ; De Simone I; Provenzale I; Fernández DI; Brouns SLN; Farndale RW; Henskens YMC; Kuijpers MJE; Ten Cate H; van der Meijden PEJ; Cavill R; Heemskerk JWM
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181592
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice.
Llop-Guevara A; Porras M; Cendón C; Di Ceglie I; Siracusa F; Madarena F; Rinotas V; Gómez L; van Lent PL; Douni E; Chang HD; Kamradt T; Román J
Arthritis Res Ther; 2015 Dec; 17():356. PubMed ID: 26653844
[TBL] [Abstract][Full Text] [Related]
10. Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.
Wang X; Mychajlowycz M; Lau C; Gutierrez C; Scott JA; Chow CW
J Pharmacol Exp Ther; 2012 Feb; 340(2):277-85. PubMed ID: 22031919
[TBL] [Abstract][Full Text] [Related]
11. The Novel Oral Syk Inhibitor, Bl1002494, Protects Mice From Arterial Thrombosis and Thromboinflammatory Brain Infarction.
van Eeuwijk JM; Stegner D; Lamb DJ; Kraft P; Beck S; Thielmann I; Kiefer F; Walzog B; Stoll G; Nieswandt B
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1247-53. PubMed ID: 27102960
[TBL] [Abstract][Full Text] [Related]
12. Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.
Miller AL; Zhang C; Shokat KM; Lowell CA
J Immunol; 2009 Jan; 182(2):988-98. PubMed ID: 19124742
[TBL] [Abstract][Full Text] [Related]
13. Critical role of Src-Syk-PLC{gamma}2 signaling in megakaryocyte migration and thrombopoiesis.
Mazharian A; Thomas SG; Dhanjal TS; Buckley CD; Watson SP
Blood; 2010 Aug; 116(5):793-800. PubMed ID: 20457868
[TBL] [Abstract][Full Text] [Related]
14. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of spleen tyrosine kinase as treatment of postoperative ileus.
van Bree SH; Gomez-Pinilla PJ; van de Bovenkamp FS; Di Giovangiulio M; Farro G; Nemethova A; Cailotto C; de Jonge WJ; Lee K; Ramirez-Molina C; Lugo D; Skynner MJ; Boeckxstaens GE; Matteoli G
Gut; 2013 Nov; 62(11):1581-90. PubMed ID: 23242119
[TBL] [Abstract][Full Text] [Related]
16. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.
Young RM; Hardy IR; Clarke RL; Lundy N; Pine P; Turner BC; Potter TA; Refaeli Y
Blood; 2009 Mar; 113(11):2508-16. PubMed ID: 18981293
[TBL] [Abstract][Full Text] [Related]
17. SYK inhibition and response prediction in diffuse large B-cell lymphoma.
Cheng S; Coffey G; Zhang XH; Shaknovich R; Song Z; Lu P; Pandey A; Melnick AM; Sinha U; Wang YL
Blood; 2011 Dec; 118(24):6342-52. PubMed ID: 22025527
[TBL] [Abstract][Full Text] [Related]
18. Spleen tyrosine kinase suppresses osteoblastic differentiation through MAPK and PKCα.
Yoshida K; Higuchi C; Nakura A; Yoshikawa H
Biochem Biophys Res Commun; 2011 Aug; 411(4):774-9. PubMed ID: 21782794
[TBL] [Abstract][Full Text] [Related]
19. Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors.
Choi JS; Hwang HJ; Kim SW; Lee BI; Lee J; Song HJ; Koh JS; Kim JH; Lee PH
Bioorg Med Chem Lett; 2015 Oct; 25(20):4441-6. PubMed ID: 26384287
[TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets.
Law DA; Nannizzi-Alaimo L; Ministri K; Hughes PE; Forsyth J; Turner M; Shattil SJ; Ginsberg MH; Tybulewicz VL; Phillips DR
Blood; 1999 Apr; 93(8):2645-52. PubMed ID: 10194444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
